Schwann cells differentiated from skin-derived precursors provide neuroprotection via autophagy inhibition in a cellular model of Parkinson’s disease

Autophagy has been shown to play an important role in Parkinson’s disease. We hypothesized that skin-derived precursor cells exhibit neuroprotective effects in Parkinson’s disease through affecting autophagy. In this study, 6-hydroxydopamine-damaged SH-SY5Y cells were pretreated with a culture mediu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jia-Nan Yan, Hai-Ying Zhang, Jun-Rui Li, Ying Chen, Yong-Cheng Jiang, Jia-Bing Shen, Kai-Fu Ke, Xiao-Su Gu
Formato: article
Lenguaje:EN
Publicado: Wolters Kluwer Medknow Publications 2022
Materias:
Acceso en línea:https://doaj.org/article/4eb2331ff0b84061875ba3822553891b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4eb2331ff0b84061875ba3822553891b
record_format dspace
spelling oai:doaj.org-article:4eb2331ff0b84061875ba3822553891b2021-11-19T12:16:44ZSchwann cells differentiated from skin-derived precursors provide neuroprotection via autophagy inhibition in a cellular model of Parkinson’s disease1673-537410.4103/1673-5374.327353https://doaj.org/article/4eb2331ff0b84061875ba3822553891b2022-01-01T00:00:00Zhttp://www.nrronline.org/article.asp?issn=1673-5374;year=2022;volume=17;issue=6;spage=1357;epage=1363;aulast=Yanhttps://doaj.org/toc/1673-5374Autophagy has been shown to play an important role in Parkinson’s disease. We hypothesized that skin-derived precursor cells exhibit neuroprotective effects in Parkinson’s disease through affecting autophagy. In this study, 6-hydroxydopamine-damaged SH-SY5Y cells were pretreated with a culture medium containing skin-derived precursors differentiated into Schwann cells (SKP-SCs). The results showed that the SKP-SC culture medium remarkably enhanced the activity of SH-SY5Y cells damaged by 6-hydroxydopamine, reduced excessive autophagy, increased tyrosine hydroxylase expression, reduced α-synuclein expression, reduced the autophagosome number, and activated the PI3K/AKT/mTOR pathway. Autophagy activator rapamycin inhibited the effects of SKP-SCs, and autophagy inhibitor 3-methyladenine had the opposite effect. These findings confirm that SKP-SCs modulate the PI3K/AKT/mTOR pathway to inhibit autophagy, thereby exhibiting a neuroprotective effect in a cellular model of Parkinson’s disease. This study was approved by the Animal Ethics Committee of Laboratory Animal Center of Nantong University (approval No. S20181009-205) on October 9, 2018.Jia-Nan YanHai-Ying ZhangJun-Rui LiYing ChenYong-Cheng JiangJia-Bing ShenKai-Fu KeXiao-Su GuWolters Kluwer Medknow Publicationsarticlealpha-synuclein; autophagosomes; autophagy; neural regeneration; neuroprotection; parkinson′s disease; pi3k/akt/mtor pathway; skin-derived precursor schwann cellsNeurology. Diseases of the nervous systemRC346-429ENNeural Regeneration Research, Vol 17, Iss 6, Pp 1357-1363 (2022)
institution DOAJ
collection DOAJ
language EN
topic alpha-synuclein; autophagosomes; autophagy; neural regeneration; neuroprotection; parkinson′s disease; pi3k/akt/mtor pathway; skin-derived precursor schwann cells
Neurology. Diseases of the nervous system
RC346-429
spellingShingle alpha-synuclein; autophagosomes; autophagy; neural regeneration; neuroprotection; parkinson′s disease; pi3k/akt/mtor pathway; skin-derived precursor schwann cells
Neurology. Diseases of the nervous system
RC346-429
Jia-Nan Yan
Hai-Ying Zhang
Jun-Rui Li
Ying Chen
Yong-Cheng Jiang
Jia-Bing Shen
Kai-Fu Ke
Xiao-Su Gu
Schwann cells differentiated from skin-derived precursors provide neuroprotection via autophagy inhibition in a cellular model of Parkinson’s disease
description Autophagy has been shown to play an important role in Parkinson’s disease. We hypothesized that skin-derived precursor cells exhibit neuroprotective effects in Parkinson’s disease through affecting autophagy. In this study, 6-hydroxydopamine-damaged SH-SY5Y cells were pretreated with a culture medium containing skin-derived precursors differentiated into Schwann cells (SKP-SCs). The results showed that the SKP-SC culture medium remarkably enhanced the activity of SH-SY5Y cells damaged by 6-hydroxydopamine, reduced excessive autophagy, increased tyrosine hydroxylase expression, reduced α-synuclein expression, reduced the autophagosome number, and activated the PI3K/AKT/mTOR pathway. Autophagy activator rapamycin inhibited the effects of SKP-SCs, and autophagy inhibitor 3-methyladenine had the opposite effect. These findings confirm that SKP-SCs modulate the PI3K/AKT/mTOR pathway to inhibit autophagy, thereby exhibiting a neuroprotective effect in a cellular model of Parkinson’s disease. This study was approved by the Animal Ethics Committee of Laboratory Animal Center of Nantong University (approval No. S20181009-205) on October 9, 2018.
format article
author Jia-Nan Yan
Hai-Ying Zhang
Jun-Rui Li
Ying Chen
Yong-Cheng Jiang
Jia-Bing Shen
Kai-Fu Ke
Xiao-Su Gu
author_facet Jia-Nan Yan
Hai-Ying Zhang
Jun-Rui Li
Ying Chen
Yong-Cheng Jiang
Jia-Bing Shen
Kai-Fu Ke
Xiao-Su Gu
author_sort Jia-Nan Yan
title Schwann cells differentiated from skin-derived precursors provide neuroprotection via autophagy inhibition in a cellular model of Parkinson’s disease
title_short Schwann cells differentiated from skin-derived precursors provide neuroprotection via autophagy inhibition in a cellular model of Parkinson’s disease
title_full Schwann cells differentiated from skin-derived precursors provide neuroprotection via autophagy inhibition in a cellular model of Parkinson’s disease
title_fullStr Schwann cells differentiated from skin-derived precursors provide neuroprotection via autophagy inhibition in a cellular model of Parkinson’s disease
title_full_unstemmed Schwann cells differentiated from skin-derived precursors provide neuroprotection via autophagy inhibition in a cellular model of Parkinson’s disease
title_sort schwann cells differentiated from skin-derived precursors provide neuroprotection via autophagy inhibition in a cellular model of parkinson’s disease
publisher Wolters Kluwer Medknow Publications
publishDate 2022
url https://doaj.org/article/4eb2331ff0b84061875ba3822553891b
work_keys_str_mv AT jiananyan schwanncellsdifferentiatedfromskinderivedprecursorsprovideneuroprotectionviaautophagyinhibitioninacellularmodelofparkinsonsdisease
AT haiyingzhang schwanncellsdifferentiatedfromskinderivedprecursorsprovideneuroprotectionviaautophagyinhibitioninacellularmodelofparkinsonsdisease
AT junruili schwanncellsdifferentiatedfromskinderivedprecursorsprovideneuroprotectionviaautophagyinhibitioninacellularmodelofparkinsonsdisease
AT yingchen schwanncellsdifferentiatedfromskinderivedprecursorsprovideneuroprotectionviaautophagyinhibitioninacellularmodelofparkinsonsdisease
AT yongchengjiang schwanncellsdifferentiatedfromskinderivedprecursorsprovideneuroprotectionviaautophagyinhibitioninacellularmodelofparkinsonsdisease
AT jiabingshen schwanncellsdifferentiatedfromskinderivedprecursorsprovideneuroprotectionviaautophagyinhibitioninacellularmodelofparkinsonsdisease
AT kaifuke schwanncellsdifferentiatedfromskinderivedprecursorsprovideneuroprotectionviaautophagyinhibitioninacellularmodelofparkinsonsdisease
AT xiaosugu schwanncellsdifferentiatedfromskinderivedprecursorsprovideneuroprotectionviaautophagyinhibitioninacellularmodelofparkinsonsdisease
_version_ 1718420069020598272